Literature DB >> 28697994

Molecular epidemiology of Dientamoeba fragilis.

Simone M Cacciò1.   

Abstract

The flagellated protozoan Dientamoeba fragilis is one of the most commonly diagnosed parasite of the human gut, with a global distribution. Nevertheless, essential aspects of its biology remain incompletely understood or controversial, most notably life cycle, host range, transmission routes and the ability to cause disease. Molecular epidemiologic studies are also scarce, and limited by the lack of informative genotyping tools. To date, two D. fragilis genotypes (1 and 2) are recognized, with a strong predominance of genotype 1 in both humans and few animal hosts. Recent studies have shown that a very low level of genetic variability characterizes parasite isolates collected in various geographic areas and from both symptomatic and asymptomatic cases. This has raised the hypothesis D. fragilis may be a clonal organism. The recent availability of transcriptome data should greatly assist the development of markers useful to understand genetic diversity of D. fragilis at the population level.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Clonality; Dientamoeba fragilis; Epidemiology: transmission; Molecular typing

Mesh:

Substances:

Year:  2017        PMID: 28697994     DOI: 10.1016/j.actatropica.2017.06.029

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  8 in total

1.  Prevalence and genetic characterization of Dientamoeba fragilis in asymptomatic children attending daycare centers.

Authors:  Ana Paula Oliveira-Arbex; Érica Boarato David; Simone Mario Cacciò; Cátia Regina Branco da Fonseca; Joelma Gonçalves Martin; Cilmery Suemi Kurokawa; Fabio Tosini; Jayme Augusto Souza Neto; Semíramis Guimarães
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2021-05-07       Impact factor: 1.846

2.  Blastocystis prevalence and subtypes in autochthonous and immigrant patients in a referral centre for parasitic infections in Italy.

Authors:  Chiara Piubelli; Hossein Soleymanpoor; Giovanni Giorli; Fabio Formenti; Dora Buonfrate; Zeno Bisoffi; Francesca Perandin
Journal:  PLoS One       Date:  2019-01-07       Impact factor: 3.240

3.  Dientamoeba fragilis - the most common intestinal protozoan in the Helsinki Metropolitan Area, Finland, 2007 to 2017.

Authors:  Jukka-Pekka Pietilä; Taru Meri; Heli Siikamäki; Elisabet Tyyni; Anne-Marie Kerttula; Laura Pakarinen; T Sakari Jokiranta; Anu Kantele
Journal:  Euro Surveill       Date:  2019-07

4.  Investigation of neglected protists Blastocystis sp. and Dientamoeba fragilis in immunocompetent and immunodeficient diarrheal patients using both conventional and molecular methods.

Authors:  Fakhriddin Sarzhanov; Funda Dogruman-Al; Monica Santin; Jenny G Maloney; Ayse Semra Gureser; Djursun Karasartova; Aysegul Taylan-Ozkan
Journal:  PLoS Negl Trop Dis       Date:  2021-10-06

5.  Prevalence of Intestinal Parasitoses in a Non-Endemic Setting during a 10-Year Period (2011-2020): A Focus on Dientamoeba fragilis.

Authors:  Adriana Calderaro; Mirko Buttrini; Sara Montecchini; Sabina Rossi; Benedetta Farina; Maria Cristina Arcangeletti; Flora De Conto; Carlo Chezzi
Journal:  Microorganisms       Date:  2022-02-12

Review 6.  The Neglected Gut Microbiome: Fungi, Protozoa, and Bacteriophages in Inflammatory Bowel Disease.

Authors:  Gina L Guzzo; Jane M Andrews; Laura S Weyrich
Journal:  Inflamm Bowel Dis       Date:  2022-07-01       Impact factor: 7.290

7.  Dientamoeba fragilis Infection in Patients with Digestive and Non-Digestive Symptoms: A Case-Control Study.

Authors:  Yousry A Hawash; Khadiga A Ismail; Taisir Saber; Emad M Eed; Amany S Khalifa; Khalaf F Alsharif; Saleh A Alghamdi
Journal:  Korean J Parasitol       Date:  2020-04-30       Impact factor: 1.341

8.  Paromomycin is superior to metronidazole in Dientamoeba fragilis treatment.

Authors:  Ander Burgaña; Rosa Abellana; Stanislav Zlatanov Yordanov; Rabee Kazan; A Mauricio Pérez Ortiz; Cristina Castillo Ramos; Christian Garavito Hernández; Miriam Molina Rivero; Alessandra Queiroga Gonçalves; Emma Padilla; Josefa Pérez; Roger García-Puig; Tomas M Perez-Porcuna
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2019-11-11       Impact factor: 4.077

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.